Veradermics’ minoxidil pill improves hair coverage in men in Phase 3

In the wake of a successful IPO and strong stock growth throughout the year, Veradermics now has late-stage data to support a regulatory package for its hair loss pill.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top